Efficacy of Ametop Cream in Reducing Pain of Local Anesthetic Infiltration
Information source: University of British Columbia
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Pain
Intervention: Ametop cream (Drug)
Phase: Phase 1
Status: Completed
Sponsored by: University of British Columbia Official(s) and/or principal investigator(s): Vit Gunka, MD FRCPC, Principal Investigator, Affiliation: University of British Columbia
Summary
Ametop is a numbing cream used to ease the pain of having blood drawn or an IV inserted. It
is safe and virtually none enters the blood stream. It's effectiveness at reducing the pain
of the freezing injection prior to epidural/ spinal anesthesia in pregnant women has not
been studied.
Clinical Details
Official title: The Efficacy of Topical Amethocaine Gel in Reducing the Pain of Local Anesthetic Infiltration Prior to Neuraxial Anesthesia in Non-labouring Pregnant Women: A Randomized Controlled Trial
Study design: Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Health Services Research
Primary outcome: Pain score
Detailed description:
We propose to randomize 70 women to have either the numbing cream or a similar looking
moisturizing cream placed on their lower back before their anesthetic. They will rate the
discomfort of the freezing injection allowing us to compare the two groups and determine if
the numbing cream is effective.
Eligibility
Minimum age: 19 Years.
Maximum age: N/A.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- Any pregnant subject undergoing an elective procedure under neuraxial anesthesia.
Exclusion Criteria:
- Any contraindication to neuraxial anesthesia
- Subjects in labour
Locations and Contacts
BC Women's Hospital, Vancouver, British Columbia V6H 3N1, Canada
Additional Information
Starting date: May 2013
Last updated: December 10, 2013
|